IRS, Mylan Set To Square Off Over $50M Legal Fee Deduction
The Internal Revenue Service and Mylan Inc. are preparing for a trial in the U.S. Tax Court starting Monday over whether the generic drug maker can deduct $50 million in legal...To view the full article, register now.
Already a subscriber? Click here to view full article